Stacy J. Smith

Evolving therapies for multiple sclerosis.

Vivek Misra, Alireza Minagar, Eileen O'Connor, 2007, International review of neurobiology.

Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).

N. Swanson, D. Rigel, Stacy J. Smith, 2004, Journal of drugs in dermatology : JDD.

Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.

A. Minagar, W. Jy, J. Alexander, 2008, Archives of neurology.

Proteomic Analysis of Human Cerebral Endothelial Cells Activated by Multiple Sclerosis Serum and IFNβ-1b

A. Minagar, J. Alexander, M. Jennings, 2007, Journal of Molecular Neuroscience.

Proteomic analysis of human cerebral endothelial cells activated by multiple sclerosis serum and IFNbeta-1b.

A. Minagar, J. Alexander, M. Jennings, 2007, Journal of molecular neuroscience : MN.

Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis: A preliminary study

A. Minagar, R. Kelley, J. McLarty, 2007, Journal of Neuroinflammation.

Combination Therapy with Interferon Beta-1a and Doxycycline in Multiple Sclerosis an Open-label Trial

W. Jy, E. González-Toledo, R. Schwendimann, 2022 .